Hydrogen sulfide mediates the cardioprotective effects of gene therapy with PKG-Iα

Basic Research in Cardiology

Volumn 110, Issue 4, 2015, Pages

  Das, Anindita ^a   Samidurai, Arun ^a   Hoke, Nicholas N ^a   Kukreja, Rakesh C ^a   Salloum, Fadi N ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

CSE; Gene therapy; H2< inf>S; Ischemia reperfusion injury; PKG

Indexed keywords

3 MERCAPTOPYRUVATE SULFURTRANSFERASE; ADENOVIRUS VECTOR; CYCLIC GMP DEPENDENT PROTEIN KINASE 1; CYSTATHIONINE BETA SYNTHASE; CYSTATHIONINE GAMMA LYASE; HYDROGEN SULFIDE; PROPARGYLGLYCINE; SULFURTRANSFERASE; UNCLASSIFIED DRUG; CYCLIC GMP DEPENDENT PROTEIN KINASE;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DEATH; CELL STIMULATION; CONTROLLED STUDY; DRUG EFFICACY; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE CONTRACTION; HEART MUSCLE CELL; HEART PROTECTION; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; RAT; REOXYGENATION; REPERFUSION INJURY; SIGNAL TRANSDUCTION; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY; ANIMAL; CELL CULTURE; GENE THERAPY; GENETICS; METABOLISM; MYOCARDIAL REPERFUSION INJURY; PHYSIOLOGY; WISTAR RAT;

ANIMALS; CELLS, CULTURED; CYCLIC GMP-DEPENDENT PROTEIN KINASE TYPE I; CYCLIC GMP-DEPENDENT PROTEIN KINASES; GENETIC THERAPY; HYDROGEN SULFIDE; MALE; MICE; MYOCARDIAL REPERFUSION INJURY; RATS; RATS, WISTAR;

EID: 84930616453     PISSN: 03008428     EISSN: 14351803     Source Type: Journal    
DOI: 10.1007/s00395-015-0500-y     Document Type: Article

References (51)

1. Altaany Z, Moccia F, Munaron L, Mancardi D, Wang R (2014) Hydrogen sulfide and endothelial dysfunction: relationship with nitric oxide. Curr Med Chem 21:3646–3661. doi:10.2174/0929867321666140706142930
2. Bibli SI, Yang G, Zhou Z, Wang R, Topouzis S, Papapetropoulos A (2015) Role of cGMP in hydrogen sulfide signaling. Nitric Oxide 46:7–13. doi:10.1016/j.niox.2014.12.004
3. Bice JS, Baxter GF (2014) Postconditioning signaling in the heart: mechanisms and translatability. Br J Pharmacol. doi:10.1111/bph.12976
4. Burgoyne JR, Prysyazhna O, Rudyk O, Eaton P (2012) cGMP-dependent activation of protein kinase G precludes disulfide activation: implications for blood pressure control. Hypertension 60:1301–1308. doi:10.1161/HYPERTENSIONAHA.112.198754
5. Burgoyne JR, Oka S, Ale-Agha N, Eaton P (2013) Hydrogen peroxide sensing and signaling by protein kinases in the cardiovascular system. Antioxid Redox Signal 18:1042–1052. doi:10.1089/ars.2012.4817
6. Burley DS, Ferdinandy P, Baxter GF (2007) Cyclic GMP and protein kinase-G in myocardial ischaemia-reperfusion: opportunities and obstacles for survival signaling. Br J Pharmacol 152:855–869. doi:10.1038/sj.bjp.0707453
7. Calvert JW, Elston M, Nicholson CK, Gundewar S, Jha S, Elrod JW, Ramachandran A, Lefer DJ (2010) Genetic and pharmacologic hydrogen sulfide therapy attenuates ischemia-induced heart failure in mice. Circulation 122:11–19. doi:10.1161/CIRCULATIONAHA.109.920991
8. Cen B, Deguchi A, Weinstein IB (2008) Activation of protein kinase G Increases the expression of p21CIP1, p27KIP1, and histidine triad protein 1 through Sp1. Cancer Res 68:5355–5362. doi:10.1158/0008-5472.CAN-07-6869
9. Chau VQ, Salloum FN, Hoke NN, Abbate A, Kukreja RC (2011) Mitigation of the progression of heart failure with sildenafil involves inhibition of RhoA/Rho-kinase pathway. Am J Physiol Heart Circ Physiol 300:H2272–H2279. doi:10.1152/ajpheart.00654.2010
10. Cohen MV, Downey JM (2014) Signalling pathways and mechanisms of protection in pre- and postconditioning: historical perspective and lessons for the future. Br J Pharmacol. doi:10.1111/bph.12903
11. D’Souza SP, Yellon DM, Martin C, Schulz R, Heusch G, Onody A, Ferdinandy P, Baxter GF (2003) B-type natriuretic peptide limits infarct size in rat isolated hearts via KATP channel opening. Am J Physiol Heart Circ Physiol 284:H1592–H1600. doi:10.1152/ajpheart.00902.2002
12. Das A, Salloum FN, Xi L, Rao YJ, Kukreja RC (2009) ERK phosphorylation mediates sildenafil-induced myocardial protection against ischemia-reperfusion injury in mice. Am J Physiol Heart Circ Physiol 296:H1236–H1243. doi:10.1152/ajpheart.00100.2009
13. Das A, Salloum FN, Xi L, Rao YJ, Kukreja RC (2009) Role of ERK1/2 phosphorylation in sildenafil-induced myocardial protection against ischemia-reperfusion injury in mice. Am J Physiol Heart Circ Physiol 296:H1236–H1243. doi:10.1152/ajpheart.00100.2009
14. Das A, Smolenski A, Lohmann SM, Kukreja RC (2006) Cyclic GMP-dependent protein kinase Ialpha attenuates necrosis and apoptosis following ischemia/reoxygenation in adult cardiomyocyte. J Biol Chem 281:38644–38652. doi:10.1074/jbc.M606142200
15. Das A, Xi L, Kukreja RC (2005) Phosphodiesterase-5 inhibitor sildenafil preconditions adult cardiac myocytes against necrosis and apoptosis: essential role of nitric oxide signaling. J Biol Chem 280:12944–12955. doi:10.1074/jbc.M404706200
16. Das A, Xi L, Kukreja RC (2008) Protein kinase G-dependent cardioprotective mechanism of phosphodiesterase-5 inhibition involves phosphorylation of ERK and GSK3beta. J Biol Chem 283:29572–29585. doi:10.1074/jbc.M801547200
17. Elrod JW, Calvert JW, Morrison J, Doeller JE, Kraus DW, Tao L, Jiao X, Scalia R, Kiss L, Szabo C, Kimura H, Chow CW, Lefer DJ (2007) Hydrogen sulfide attenuates myocardial ischemia-reperfusion injury by preservation of mitochondrial function. Proc Natl Acad Sci USA 104:15560–15565. doi:10.1073/pnas.0705891104
18. Francis SH, Corbin JD (1999) Cyclic nucleotide-dependent protein kinases: intracellular receptors for cAMP and cGMP action. Crit Rev Clin Lab Sci 36:275–328. doi:10.1080/10408369991239213
19. Geng B, Yang J, Qi Y, Zhao J, Pang Y, Du J, Tang C (2004) H2S generated by heart in rat and its effects on cardiac function. Biochem Biophys Res Commun 313:362–368. doi:10.1016/j.bbrc.2003.11.130
20. Gotz KR, Sprenger JU, Perera RK, Steinbrecher JH, Lehnart SE, Kuhn M, Gorelik J, Balligand JL, Nikolaev VO (2014) Transgenic mice for real-time visualization of cGMP in intact adult cardiomyocytes. Circ Res 114:1235–1245. doi:10.1161/CIRCRESAHA.114.302437
21. Han J, Kim N, Kim E, Ho WE, Earm YE (2001) Modulation of ATP-sensitive potassium channels by cGMP-dependent protein kinase in rabbit ventricular myocytes. J Biol Chem 276:22140–22147. doi:10.1074/jbc.M010103200
22. Hofmann F, Ammendola A, Schlossmann J (2000) Rising behind NO: cGMP-dependent protein kinases. J Cell Sci 113:1671–1676
23. Hou J, Kang YJ (2012) Regression of pathological cardiac hypertrophy: signaling pathways and therapeutic targets. Pharmacol Ther 135:337–354. doi:10.1016/j.pharmthera.2012.06.006
24. Ishii I, Akahoshi N, Yu XN, Kobayashi Y, Namekata K, Komaki G, Kimura H (2004) Murine cystathionine gamma-lyase: complete cDNA and genomic sequesnces, promoter activity, tissue distribution and developmental expression. Biochem J 381:113–123
25. Keilbach A, Ruth P, Hofmann F (1992) Detection of cGMP dependent protein kinase isozymes by specific antibodies. Eur J Biochem 208:467–473. doi:10.1111/j.1432-1033.1992.tb17209.x
26. King AL, Polhemus DJ, Bhushan S, Otsuka H, Kondo K, Nicholson CK, Bradley JM, Islam KN, Calvert JW, Tao YX, Dugas TR, Kelley EE, Elrod JW, Huang PL, Wang R, Lefer DJ (2014) Hydrogen sulfide cytoprotective signaling is endothelial nitric oxide synthase-nitric oxide dependent. Proc Natl Acad Sci USA 111:3182–3187. doi:10.1073/pnas.1321871111
27. Kondo K, Bhushan S, King AL, Prabhu SD, Hamid T, Koenig S, Murohara T, Predmore BL, Gojon G Sr, Gojon G Jr, Wang R, Karusula N, Nicholson CK, Calvert JW, Lefer DJ (2013) H2S protects against pressure overload-induced heart failure via upregulation of endothelial nitric oxide synthase. Circulation 127:1116–1127. doi:10.1161/CIRCULATIONAHA.112.000855
28. Kukreja RC (2012) Phosphodiesterase-5 and retargeting of subcellular cGMP signaling during pathological hypertrophy. Circulation 126:916–919. doi:10.1161/CIRCULATIONAHA.112.124966
29. Kukreja RC, Salloum F, Das A, Ockaili R, Yin C, Bremer YA, Fisher PW, Wittkamp M, Hawkins J, Chou E, Kukreja AK, Wang X, Marwaha V, Xi L (2005) Pharmacological preconditioning with sildenafil: basic mechanisms and clinical implications. Vascul Pharmacol 42:219–232. doi:10.1016/j.vph.2005.02.010
30. Kukreja RC, Salloum FN, Das A (2012) Cyclic guanosine monophosphate signaling and phosphodiesterase-5 inhibitors in cardioprotection. J Am Coll Cardiol 59:1921–1927. doi:10.1016/j.jacc.2011.09.086
31. Lukowski R, Rybalkin SD, Loga F, Leiss V, Beavo JA, Hofmann F (2010) Cardiac hypertrophy is not amplified by deletion of cGMP-dependent protein kinase I in cardiomyocytes. Proc Natl Acad Sci USA 107:5646–5651. doi:10.1073/pnas.1001360107
32. Methner C, Lukowski R, Grube K, Loga F, Smith RA, Murphy MP, Hofmann F, Krieg T (2013) Protection through postconditioning or a mitochondria-targeted S-nitrosothiol is unaffected by cardiomyocyte-selective ablation of protein kinase G. Basic Res Cardiol 108:337. doi:10.1007/s00395-013-0337-1
33. Ockaili R, Salloum F, Hawkins J, Kukreja RC (2002) Sildenafil (Viagra) induces powerful cardioprotective effect via opening of mitochondrial K(ATP) channels in rabbits. Am J Physiol Heart Circ Physiol 283:H1263–H1269. doi:10.1152/ajpheart.00324.2002
34. Paulus WJ, Tschöpe C (2013) A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. J Am Coll Cardiol 62:263–271. doi:10.1016/j.jacc.2013.02.092
35. Polhemus DJ, Lefer DJ (2014) Emergence of hydrogen sulfide as an endogenous gaseous signaling molecule in cardiovascular disease. Circ Res 114:730–737. doi:10.1161/CIRCRESAHA.114.300505
36. Pryor WA, Houk KN, Foote CS, Fukuto JM, Ignarro LJ, Squadrito GL, Davies KJ (2006) Free radical biology and medicine: it’s a gas, man! Am J Physiol Regul Integr Comp Physiol 291:R491–R511. doi:10.1152/ajpregu.00614.2005
37. Qin Q, Yang XM, Cui L, Critz SD, Cohen MV, Browner NC, Lincoln TM, Downey JM (2004) Exogenous NO triggers preconditioning via a cGMP- and mitoKATP-dependent mechanism. Am J Physiol Heart Circ Physiol 287:H712–H718. doi:10.1152/ajpheart.00954.2003
38. Rassaf T, Totzeck M, Hendgen-Cotta UB, Shiva S, Heusch G, Kelm M (2014) Circulating nitrite contributes to cardioprotection by remote ischemic preconditioning. Circ Res 114:1601–1610. doi:10.1161/CIRCRESAHA.114.303822
39. Salloum FN (2015) Hydrogen sulfide and cardioprotection—mechanistic insights and clinical translatability. Pharmacol Ther. doi:10.1016/j.pharmthera.2015.04.004
40. Salloum FN, Abbate A, Das A, Houser J, Mudrick CA, Qureshi IZ, Hoke NN, Roy SK, Brown WR, Prabhakar S, Kukreja RC (2008) Sildenafil (Viagra) attenuates ischemic cardiomyopathy and improves left ventricular function in mice. Am J Physiol Heart Circ Physiol 294:H1398–H1406. doi:10.1152/ajpheart.91438.2007
41. Salloum FN, Chau VQ, Hoke NN, Abbate A, Varma A, Ockaili RA, Toldo S, Kukreja RC (2009) Phosphodiesterase-5 inhibitor, tadalafil, protects against myocardial ischemia/reperfusion through protein-kinase G dependent generation of hydrogen sulfide. Circulation 120:S31–S36. doi:10.1161/CIRCULATIONAHA.108.843979
42. Salloum FN, Das A, Samidurai A, Hoke NN, Chau VQ, Ockaili RA, Stasch JP, Kukreja RC (2012) Cinaciguat, a novel activator of soluble guanylate cyclase, protects against ischemia/reperfusion injury: role of hydrogen sulfide. Am J Physiol Heart Circ Physiol 302:H1347–H1354. doi:10.1152/ajpheart.00544.2011
43. Salloum FN, Ockaili R, Wittkamp M, Marwaha VR, Kukreja RC (2006) Vardenafil: a novel type 5 phosphodiesterase inhibitor reduces myocardial infarct size following ischemia/reperfusion injury via opening of mitochondrial KATP channels in rabbits. J Mol Cell Cardiol 40:405–411. doi:10.1016/j.yjmcc.2005.10.002
44. Stubbert D, Prysyazhna O, Rudyk O, Scotcher J, Burgoyne JR, Eaton P (2014) Protein kinase G Iα oxidation paradoxically underlies blood pressure lowering by the reductant hydrogen sulfide. Hypertension 64:1344–1351. doi:10.1161/HYPERTENSIONAHA.114.04281
45. Su YW, Liang C, Jin HF, Tang XY, Han W, Chai LJ, Zhang CY, Geng B, Tang CS, Du JB (2009) Hydrogen sulfide regulates cardiac function and structure in adriamycin-induced cardiomyopathy. Circ J 73:741–749
46. Toldo S, Das A, Mezzaroma E, Chau VQ, Marchetti C, Durrant D, Samidurai A, Van Tassell BW, Yin C, Ockaili RA, Vigneshwar N, Mukhopadhyay ND, Kukreja RC, Abbate A, Salloum FN (2014) Induction of microRNA-21 with exogenous hydrogen sulfide attenuates myocardial ischemic and inflammatory injury in mice. Circ Cardiovasc Genet 7:311–320. doi:10.1161/CIRCGENETICS.113.000381
47. Varma A, Das A, Hoke NN, Durrant DE, Salloum FN, Kukreja RC (2012) Anti-inflammatory and cardioprotective effects of tadalafil in diabetic mice. PLoS One 7:e45243. doi:10.1371/journal.pone.0045243
48. Wollert KC, Fiedler B, Gambaryan S, Smolenski A, Heineke J, Butt E, Trautwein C, Lohmann SM, Drexler H (2002) Gene transfer of cGMP-dependent protein kinase I enhances the antihypertrophic effects of nitric oxide in cardiomyocytes. Hypertension 39:87–92
49. Yang G, Pei Y, Teng H, Cao Q, Wang R (2011) Specificity protein-1 as a critical regulator of human cyctathionine gamma-lyase in smooth muscle cells. J Biol Chem 286:26450–26460. doi:10.1074/jbc.M111.266643
50. Yong QC, Lee SW, Foo CS, Neo KL, Chen X, Bian JS (2008) Endogenous hydrogen sulphide mediates the cardioprotection induced by ischemic postconditioning. Am J Physiol Heart Circ Physiol 295:H1330–H1340. doi:10.1152/ajpheart.00244.2008
51. Yong QC, Pan TT, Hu LF, Bian JS (2008) Negative regulation of beta-adrenergic function by hydrogen sulphide in the rat hearts. J Mol Cell Cardiol 44:701–710. doi:10.1016/j.yjmcc.2008.01.007